We assessed CD34 expression in mixed-population clinical samples of CP (42), AP (9), APcyto (8), and BC (28) patients (dataset GSE4170)17 to obtain CD34+ similarity scores as a corresponding patient parameter and indicator of disease status (Supplementary Resources and Methods). This evidence concerns the gene CP and breast cancer.